Benjamin Hohl insider trades
Open-market stock purchases and sales by Benjamin Hohl, CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc, from SEC Form 4 filings since Feb 23, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $177K |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $111K |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $14.9K |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Aug 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $270K |
| Aug 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $82.4K |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $16.2K |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $19K |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $134K |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $141K |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $6.6K |
| Jun 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $59K |
| Jun 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $149K |
| Jun 17, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $55.4K |
| Jun 17, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Mar 6, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $296K |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Dec 22, 2025 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ELVN Enliven Therapeutics, Inc: 67 sales, last Sep 17, 2026